Weight-loss drug Zepbound now in single-dose vials at half the price

Eli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says it will now offer the medication in single-dose vials at half the price currently available to consumers. The new 2.5 milligram (mg) and 5 mg weekly dose vials differ from the standard preloaded injector pens that are used to administer Zepbound (tirzepatide) and competitors such as Wegovy (semaglutide). Instead, patients will use a syringe to withdraw the liquid drug from the vial. A four-week supply of the 2.5 mg vials will be priced at $399, and a similar supply of the 5 mg vials at $529—about half Read More